sulfonylureas
The present studies also showed that sulfonylureas, oral       hypoglycemic agents currently used in the management of type 2 diabetes,       inhibited the carnitine uptake system.
The present studies also showed that  @SUBJECT$ , oral       hypoglycemic agents currently used in the management of type 2 diabetes,        @PREDICAT$  the carnitine  @OBJECT$  system.